
英夫利昔单抗治疗炎症性肠病的潜在风险
Potential risk of monoclonal antibody of infliximab for inflammatory bowel disease
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |